CVRX INC. - COMMON STOCK

CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024

11 يناير 2024 16:30:00 بحسب Nasdaq GlobeNewswire

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans

08 يناير 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

27 ديسمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

CVRx receives FDA approval for expanded labeling of Barostim

26 ديسمبر 2023 08:05:00 بحسب Nasdaq GlobeNewswire

CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference

15 نوفمبر 2023 16:21:43 بحسب Nasdaq GlobeNewswire

CMS Increases Outpatient Payment for Barostim Procedure

03 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

CVRx Reports Third Quarter 2023 Financial and Operating Results

26 أكتوبر 2023 16:15:00 بحسب Nasdaq GlobeNewswire

CVRx to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call on October 26th, 2023

12 أكتوبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference

27 يوليو 2023 08:30:00 بحسب Nasdaq GlobeNewswire

CVRx Reports Second Quarter 2023 Financial and Operating Results

25 يوليو 2023 16:15:00 بحسب Nasdaq GlobeNewswire

CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023

11 يوليو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

CVRx Set to Join Russell 2000 & 3000 Indexes

22 يونيو 2023 16:30:00 بحسب Nasdaq GlobeNewswire

CVRx to Present at the William Blair 43rd Annual Growth Stock Conference

25 مايو 2023 08:30:00 بحسب Nasdaq GlobeNewswire

CVRx Reports First Quarter 2023 Financial and Operating Results

27 أبريل 2023 16:15:00 بحسب Nasdaq GlobeNewswire

CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023

20 أبريل 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

21 مارس 2023 11:02:23 بحسب Nasdaq GlobeNewswire

CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call

16 مارس 2023 08:30:00 بحسب Nasdaq GlobeNewswire

CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial

21 فبراير 2023 07:00:00 بحسب Nasdaq GlobeNewswire

CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

26 يناير 2023 16:15:00 بحسب Nasdaq GlobeNewswire

CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023

12 يناير 2023 17:30:00 بحسب Nasdaq GlobeNewswire